This distinction classifies patients into two dominant categories: a metabolic phenotype, characterized by comorbidities such as type 2 diabetes, hypertension, obstructive sleep apnea, and polycystic ovary syndrome), and a central/behavioral phenotype, dominated by behavioral and psychological factors such as increased cravings, emotional eating, smoking addiction, and depression
This was a serendipitous choice of animal
Injectable peptides (BPC-157, TB-500, etc.): Promising in preclinical research but still experimental
These genetic variations play a crucial role in regulating hepatic fat levels, making them key factors in the progression from MAFLD to MASH and potentially liver cancer
& Teja, A
GLP-3 may affect appetite through partially distinct mechanisms, potentially offering complementary benefits when combined with other interventions